Suzuki Chigure, Nakamura Satoko, Ishibashi-Ueda Hatsue, Yoshihara Fumiki, Kawano Yuhei
Department of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Ther Apher Dial. 2011 Feb;15(1):51-7. doi: 10.1111/j.1744-9987.2010.00873.x. Epub 2010 Oct 29.
Atherosclerosis is a major cause of mortality and morbidity among hemodialysis patients, but whether it is more severe in hemodialysis patients than in cardiovascular disease patients without chronic kidney disease is unclear. We examined 46 autopsy patients who had undergone hemodialysis, and age and sex-matched 46 patients with cardiovascular disease and an eGFR of >60 mL/min/1.73 m(2). There was no difference in the prevalence of diabetes or hypertension between the groups. We divided the aorta into four segments: A, ascending artery to arch; B, descending artery to diaphragm; C, suprarenal; and D, infrarenal. We used the classification of the American Heart Association to evaluate atherosclerosis progression. Distribution was scored by the extent to which each segment was damaged: 0, none; 1, less than 1/3; 2, more than 1/3 to less than 2/3; 3, more than 2/3. Histological examination revealed that the progression score (P < 0.05) and distribution score (P<0.005) were more severe in the hemodialysis group, especially in segment A. Regression analysis showed that atherosclerosis of segment A was related to age, gender, dyslipidemia, smoking, hemodialysis therapy, and hemodialysis duration. In hemodialysis patients, atherosclerotic changes in the aorta were more severe than in cardiovascular disease patients with an eGFR of >60 mL/min/1.73 m(2). Aortic atherosclerosis was aggravated by traditional and chronic kidney disease-related risk factors.
动脉粥样硬化是血液透析患者死亡和发病的主要原因,但在血液透析患者中它是否比无慢性肾脏病的心血管疾病患者更严重尚不清楚。我们检查了46例接受血液透析的尸检患者,并按年龄和性别匹配了46例心血管疾病患者,其估算肾小球滤过率(eGFR)>60 mL/min/1.73 m²。两组间糖尿病或高血压的患病率无差异。我们将主动脉分为四段:A段,升主动脉至主动脉弓;B段,降主动脉至膈肌;C段,肾上腺上方;D段,肾下。我们采用美国心脏协会的分类方法评估动脉粥样硬化进展情况。根据各段受损程度对分布情况进行评分:0分,无损伤;1分,小于1/3;2分,大于1/3至小于2/3;3分,大于2/3。组织学检查显示,血液透析组的进展评分(P<0.05)和分布评分(P<0.005)更高,尤其是在A段。回归分析表明,A段的动脉粥样硬化与年龄、性别、血脂异常、吸烟、血液透析治疗及血液透析时长有关。在血液透析患者中,主动脉的动脉粥样硬化改变比eGFR>60 mL/min/1.73 m²的心血管疾病患者更严重。传统及与慢性肾脏病相关的危险因素会加重主动脉粥样硬化。